188 related articles for article (PubMed ID: 10937789)
1. Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia.
Schuld A; Kraus T; Hinze-Selch D; Haack M; Pollmächer T
Acta Psychiatr Scand; 2000 Aug; 102(2):153-5. PubMed ID: 10937789
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients.
Swartz JR; Ananth J; Smith MW; Burgoyne KS; Gadasally R; Arai Y
J Clin Psychiatry; 1999 Feb; 60(2):119-21. PubMed ID: 10084639
[TBL] [Abstract][Full Text] [Related]
3. The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels.
Pollmächer T; Fenzel T; Mullington J; Hinze-Selch D
Pharmacopsychiatry; 1997 Jul; 30(4):118-21. PubMed ID: 9271776
[TBL] [Abstract][Full Text] [Related]
4. Agranulocytosis and neutropenia with typical and atypical neuroleptics.
Hong X; Wang X
Am J Psychiatry; 2001 Oct; 158(10):1736-7. PubMed ID: 11579015
[No Abstract] [Full Text] [Related]
5. Prolongation of clozapine-induced granulocytopenia associated with olanzapine.
Flynn SW; Altman S; MacEwan GW; Black LL; Greenidge LL; Honer WG
J Clin Psychopharmacol; 1997 Dec; 17(6):494-5. PubMed ID: 9408818
[No Abstract] [Full Text] [Related]
6. Olanzapine prolongation of granulocytopenia after clozapine discontinuation.
Konakanchi R; Grace JJ; Szarowicz R; Pato MT
J Clin Psychopharmacol; 2000 Dec; 20(6):703-4. PubMed ID: 11106146
[No Abstract] [Full Text] [Related]
7. Olanzapine: safe during clozapine-induced agranulocytosis.
Oyewumi LK; Al-Semaan Y
J Clin Psychopharmacol; 2000 Apr; 20(2):279-81. PubMed ID: 10770478
[No Abstract] [Full Text] [Related]
8. Use of cytokines in clozapine-induced agranulocytosis.
Chin-Yee I; Bezchlibnyk-Butler K; Wong L
Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
[TBL] [Abstract][Full Text] [Related]
9. Experiences with clozapine and olanzapine.
Chatterton R
Aust N Z J Psychiatry; 1998 Jun; 32(3):463. PubMed ID: 9672741
[No Abstract] [Full Text] [Related]
10. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
Kolli V; Denton K; Borra D; Pulluri M; Sharma A
Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
[TBL] [Abstract][Full Text] [Related]
11. G-CSF plasma levels in clozapine-induced neutropenia.
Jauss M; Pantel J; Werle E; Schröder J
Biol Psychiatry; 2000 Dec; 48(11):1113-5. PubMed ID: 11094146
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution.
Teter CJ; Early JJ; Frachtling RJ
J Clin Psychiatry; 2000 Nov; 61(11):872-3. PubMed ID: 11105743
[No Abstract] [Full Text] [Related]
13. Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine.
Schuld A; Kraus T; Haack M; Hinze-Selch D; Kühn M; Pollmächer T
Schizophr Res; 2000 Jun; 43(2-3):164-6. PubMed ID: 11001592
[No Abstract] [Full Text] [Related]
14. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
15. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
Joffe G; Eskelinen S; Sailas E
Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
[No Abstract] [Full Text] [Related]
16. Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
van de Loosdrecht AA; Faber HJ; Hordijk P; Uges DR; Smit A
Neth J Med; 1998 Jan; 52(1):26-9. PubMed ID: 9573739
[TBL] [Abstract][Full Text] [Related]
17. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
18. N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopenia.
Combs MD; Perry PJ; Bever KA
Pharmacotherapy; 1997; 17(6):1300-4. PubMed ID: 9399615
[TBL] [Abstract][Full Text] [Related]
19. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R
J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615
[TBL] [Abstract][Full Text] [Related]
20. Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine.
Boot E; de Haan L
Psychopharmacology (Berl); 2000 Jun; 150(3):347-8. PubMed ID: 10923763
[No Abstract] [Full Text] [Related]
[Next] [New Search]
